Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition for treating aplastic anemia caused by spleen-kidney yang deficiency
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for aplastic and spleen-kidney yang-deficiency types, which can be used in drug combinations, blood diseases, and pharmaceutical formulations, and can solve problems such as unsatisfactory therapeutic effects, severe adverse reactions, and difficulty in long-term application
Inactive Publication Date: 2017-06-13
钱建荣
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] Drugs for the treatment of aplastic anemia are expensive, costly and unsatisfactory
Modern medicine generally uses blood transfusion therapy combined with western medicine to treat aplastic anemia of spleen and kidney yang deficiency, but the adverse reactions are serious and it is difficult to use it for a long time
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0067] A pharmaceutical composition for treating aplastic anemia of spleen-kidney yang deficiency type, which is prepared from the following raw materials: 10 parts of ginseng, 20 parts of sword bark, 20 parts of Ganoderma lucidum, 12 parts of Astragalus, 15 parts of Atractylodes Rhizoma, 12 parts of Rehmannia, 12 parts of Chinese yam, 15 parts of dogwood, 15 parts of dodder, 8 parts of Morindaofficinalis, 8 parts of psoralen, 20 parts of Cistanche, 10 parts of tea tree root, 35 parts of black bean skin, 12 parts of angelica, 8 parts of cinnamon, 15 parts of antler gum, 15 parts of kidney grass, 10 parts of Hedyotis diffusa, and 6 parts of two-color tonic grass.
Embodiment 2
[0069] A medicinal composition for treating aplastic anemia of spleen-kidney yang deficiency type, which is made from the following raw materials: 25 parts of ginseng, 30 parts of scabbardfungus, 35 parts of ganoderma lucidum, 22 parts of astragalus, 20 parts of Atractylodes Rhizoma, 22 parts of Rehmannia, 22 parts of yam, 25 parts of dogwood, 22 parts of dodder, 15 parts of Morindaofficinalis, 16 parts of psoralen, 30 parts of Cistanche, 20 parts of tea tree root, 50 parts of black bean skin, 25 parts of angelica, 12 parts of cinnamon, 25 parts of antler gum, 25 parts of kidney grass, 20 parts of Hedyotis diffusa, 18 parts of two-color tonic grass.
Embodiment 3
[0071] A pharmaceutical composition for treating aplastic anemia of spleen-kidney yang deficiency type, which is prepared from the following raw materials: 22 parts of ginseng, 25 parts of sword bark, 30 parts of Ganoderma lucidum, 16 parts of Astragalus, 16 parts of Atractylodes Rhizoma, 16 parts of Rehmannia, 16 parts of yam, 22 parts of dogwood, 18 parts of dodder, 12 parts of Morinda officinalis, 12 parts of psoralen, 25 parts of Cistanche, 16 parts of tea tree root, 45 parts of black bean skin, 22 parts of angelica, 9 parts of cinnamon, 22 parts of antler gum, 22 parts of kidney grass, 15 parts of Hedyotis diffusa, and 12 parts of two-color tonic grass.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a pharmaceutical composition for treating aplastic anemia caused by spleen-kidneyyang deficiency. The pharmaceutical composition is prepared from the following crude drugs in parts by weight: 10-25 parts of ginseng, 20-30 parts of phellinus torulosus, 20-35 parts of ganoderma lucidum, 12-22 parts of astragalus membranaceus, 15-20 parts of rhizoma atractylodis macrocephalae, 12-22 parts of radix rehmanniae preparata, 12-22 parts of Chinese yam, 15-25 parts of dogwood, 15-22 parts of semen cuscutae, 8-15 parts of morindaofficinalis, 8-16 parts of fructus psoraleae, 20-30 parts of cistanche, 10-20 parts of tea tree roots, 35-50 parts of black bean peel, 12-25 parts of angelica sinensis, 8-12 parts of cinnamon, 15-25 parts of deer-horn glue, 15-25 parts of all-grass of lance lerminium, 10-20 parts of oldenlandia diffusa and 6-18 parts of limonium bicolor. The invention aims at providing the pharmaceutical composition which is good in treatment effect, high in effective rate and free of toxic or side effect in human body for treating aplastic anemia caused by spleen-kidneyyang deficiency.
Description
technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating aplastic anemia of spleen-kidneyyang deficiency type. Background technique [0002] Aplastic anemia (AA, aplastic anemia) is a bone marrow hematopoietic failure disease, mainly manifested as bone marrow hematopoietic hypofunction, pancytopenia and anemia, bleeding, infection syndrome. The main clinical manifestations are anemia, bleeding and infection. Aplastic anemia belongs to the categories of "consumption of labor" and "blood blood" in traditional Chinese medicine. The main symptoms are anemia, bleeding, infection, and fever are mild. [0003] Western medicine has not fully elucidated the etiology and difficult to treat. Traditional therapy requires regular blood transfusion, fluid infusion and hospitalization. The cure rate is low, and the economic burden is heavy, which brings pain to patients and their families and loses confidenc...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More